NO20011173L - Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer - Google Patents

Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer

Info

Publication number
NO20011173L
NO20011173L NO20011173A NO20011173A NO20011173L NO 20011173 L NO20011173 L NO 20011173L NO 20011173 A NO20011173 A NO 20011173A NO 20011173 A NO20011173 A NO 20011173A NO 20011173 L NO20011173 L NO 20011173L
Authority
NO
Norway
Prior art keywords
fats
preparations
methods
intestinal absorption
increasing intestinal
Prior art date
Application number
NO20011173A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011173D0 (no
Inventor
David W Yesair
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Publication of NO20011173D0 publication Critical patent/NO20011173D0/no
Publication of NO20011173L publication Critical patent/NO20011173L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004—Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20011173A 1998-09-08 2001-03-07 Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer NO20011173L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08
PCT/US1999/020427 WO2000013689A1 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Publications (2)

Publication Number Publication Date
NO20011173D0 NO20011173D0 (no) 2001-03-07
NO20011173L true NO20011173L (no) 2001-05-08

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011173A NO20011173L (no) 1998-09-08 2001-03-07 Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer

Country Status (13)

Country Link
US (1) US6426069B1 (xx)
EP (1) EP1119360B1 (xx)
JP (1) JP4700193B2 (xx)
CN (1) CN1321089A (xx)
AT (1) ATE347371T1 (xx)
AU (1) AU771901B2 (xx)
CA (1) CA2343116C (xx)
DE (1) DE69934325T2 (xx)
IL (2) IL141801A0 (xx)
NO (1) NO20011173L (xx)
NZ (1) NZ510536A (xx)
WO (1) WO2000013689A1 (xx)
ZA (1) ZA200102268B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161178A0 (en) * 2001-10-11 2004-08-31 Biomolecular Products Inc MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
EP1350435B1 (en) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
WO2004069203A2 (en) * 2003-01-31 2004-08-19 Childrens Hospital Los Angeles Research Institute Oral compositions of fenretinide having increased bioavailability and methods of using the same
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
WO2012053306A1 (ja) * 2010-10-22 2012-04-26 学校法人 福岡大学 胃上皮性腫瘍（腺腫・胃癌）の診断に有用な白色不透明物質を応用した内視鏡観察法および診断能改善組成物
US20120121691A1 (en) * 2010-11-15 2012-05-17 Texas Tech University System Method for Increasing the Production of a Specific ACYL-Chain Dihydroceramide(s) for Improving the Effectiveness of Cancer Treatments
AU2019342421A1 (en) * 2018-09-21 2021-02-18 Société des Produits Nestlé S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
CA2089003C (en) 1990-08-13 2001-03-20 David W. Yesair Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
JPH11506780A (ja) * 1995-06-06 1999-06-15 バイオモレキュラー プロダクツ，インク． 薬またはカロリー送達用の混合脂質−重炭酸塩コロイド粒子
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
PT1019068E (pt) 1996-09-11 2009-10-08 Elizabeth Shanahan-Prendergast Formulações terapêuticas contendo veneno de serpente e/ou insecto para a profilaxia e terapia de neoplasmas

Also Published As

Publication number Publication date
JP2002524417A (ja) 2002-08-06
CA2343116C (en) 2008-11-18
EP1119360B1 (en) 2006-12-06
NZ510536A (en) 2003-07-25
DE69934325D1 (de) 2007-01-18
JP4700193B2 (ja) 2011-06-15
CN1321089A (zh) 2001-11-07
AU5705299A (en) 2000-03-27
EP1119360A4 (en) 2003-06-04
AU771901B2 (en) 2004-04-08
EP1119360A1 (en) 2001-08-01
IL141801A (en) 2009-02-11
ATE347371T1 (de) 2006-12-15
CA2343116A1 (en) 2000-03-16
US6426069B1 (en) 2002-07-30
WO2000013689A1 (en) 2000-03-16
ZA200102268B (en) 2001-09-19
DE69934325T2 (de) 2007-07-05
NO20011173D0 (no) 2001-03-07
IL141801A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
IS5566A (is) Afurðir úr karótínsskyldum fituefnahlutum sæbjúgna og aðferðir við notkun þeirra
NO20011173L (no) Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer
PT865294E (pt) Processo para a reducao ou a manutencao de niveis reduzidos de lipidos no sangue utilizando composicoes de proteina ob
EP1435946B8 (en) Linked biaryl compounds
IT1277511B1 (it) Metodo per generare visualizzazioni m-mode anatomiche
DE60136490D1 (de) Sn-38-lipidkomplexe und verfahren zu ihrer verwendung
AU1123800A (en) Method and apparatus for modeling and executing deferred award instrument plan
IS2595B (is) Prótínblanda og ferli til að einangra prótínblöndu úr vöðvavef
FR2833100B1 (fr) Procede de reconstitution d'une image d'un organe
NO953043D0 (no) Fremgangsmåte for syntetisere acetotriglyceridfett
DK0785773T3 (da) Etherlipidliposomer og deres terapeutiske anvendelse
DK0892035T3 (da) Flerfaseemulsion og fremgangsmåde til fremstilling heraf
MX9606503A (es) Inhibidores de pla2 y su uso para la inhibicion de la absorcion del colesterol interno.
NO20024722L (no) Stivelses-subtyper og lipid metabolisme
BRPI0309421B8 (pt) método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
NO20051169L (no) Fremgangsmate for a isolere et intestinalt kolesterolbindende protein
DE69622907D1 (de) Verfahren zur Herstellung von RTV-Einkomponenten-Silicon-Zusammensetzungen
DE69630666D1 (de) Wirkstoff für verbesserten fettstoffwechsel
NO975504D0 (no) Fremgangsmåte for påvisning av forbindelser som modulerer virkningene av fettproteinet
IT1293067B1 (it) Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico
FR2753200B1 (fr) Procede d'extraction de lipides provenant de la lecithine de soja, extrait lipidique obtenu et compositions dermato-cosmetiques le contenant
IL139144A0 (en) Mycobacterial inhibitors
WO2000027429A3 (en) Vaccine against papillomatous digital dermatitis (pdd)
EP0973390A4 (en) COMPOUNDS RELATED TO RETINOIDS FOR INHIBITING MEDICAL ENDOTHELIN-1 OVERPRODUCTION
PT1077694E (pt) Produtos terapeuticos de arilnitrona para o tratamento da doenca inflamatoria dointestino

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application